VEGFR-3 fusion proteins

Kari Kustaa Alitalo; Markku Michael Jeltsch

VEGFR-3 fusion proteins

Kari Kustaa Alitalo, Markku Michael Jeltsch

Tutkimusohjelmayksikkö

Tutkimustuotos: Patentti

Abstrakti

The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

Alkuperäiskieli	englanti
Julkaisuvuosi	9 syyskuuta 2008
Tila	Julkaistu - 9 syyskuuta 2008
OKM-julkaisutyyppi	H1 Myönnetyt patentit

Pääsy asiakirjaan

VEGFR-3 fusion proteins

http://patft1.uspto.gov/netacgi/nph-Parser?patentnumber=7422741

Siteeraa tätä

@misc{e93676bb1ff34696bf5567c6cf2547d5,

title = "VEGFR-3 fusion proteins",

abstract = " The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.",

author = "Alitalo, {Kari Kustaa} and Jeltsch, {Markku Michael}",

year = "2008",

month = sep,

day = "9",

language = "English",

publisher = "US Patent and Trademark Office",

address = "United States",

type = "Patent",

note = "US 7,422,741 B2",

}

TY - PAT

T1 - VEGFR-3 fusion proteins

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Markku Michael

PY - 2008/9/9

Y1 - 2008/9/9

N2 - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

AB - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

M3 - Patent

M1 - US 7,422,741 B2

Y2 - 2008/09/09

PB - US Patent and Trademark Office

ER -